DoD ManTech Program Highlights AIM Photonics’ End-to-End Role in Deployable Diagnostics

"AIM Photonics is at the forefront of innovative medical technology, like the portable blood diagnostic platform made possible through their expertise and fabrication capabilities."

As the Department of Defense continues to emphasize domestic manufacturing and warfighter readiness, portable, high-performance diagnostic technologies are gaining strategic importance. The U.S. Department of Defense Manufacturing Technology (ManTech) Program recently underscored this focus by highlighting AIM Photonics’ role in enabling innovations such as the SiPhox Home portable blood diagnostic platform.

The spotlight on AIM Photonics demonstrates how the Institute's end-to-end capabilities support the development of compact, low-cost photonic diagnostic systems that deliver rapid, lab-quality biomarker assessments. SiPhox’s platform, which is 100 times smaller and more affordable than traditional diagnostic machines, reflects how advanced photonic prototyping and manufacturing infrastructure can accelerate the transition from research to deployable medical technology.

This recognition reinforces AIM Photonics’ ability to support companies from early design through scalable fabrication, helping translate innovative concepts into real-world solutions.

Learn more about how SiPhox translates photonics innovation into scalable diagnostic platforms at https://siphoxhealth.com.